711 related articles for article (PubMed ID: 25952104)
1. Nasal and pulmonary vaccine delivery using particulate carriers.
Jia Y; Krishnan L; Omri A
Expert Opin Drug Deliv; 2015 Jun; 12(6):993-1008. PubMed ID: 25952104
[TBL] [Abstract][Full Text] [Related]
2. Subunit-based mucosal vaccine delivery systems for pulmonary delivery - Are they feasible?
Marasini N; Kaminskas LM
Drug Dev Ind Pharm; 2019 Jun; 45(6):882-894. PubMed ID: 30767591
[TBL] [Abstract][Full Text] [Related]
3. Intranasal formulations: promising strategy to deliver vaccines.
Riese P; Sakthivel P; Trittel S; Guzmán CA
Expert Opin Drug Deliv; 2014 Oct; 11(10):1619-34. PubMed ID: 24962722
[TBL] [Abstract][Full Text] [Related]
4. Mucosal delivery of vaccine antigens and its advantages in pediatrics.
De Magistris MT
Adv Drug Deliv Rev; 2006 Apr; 58(1):52-67. PubMed ID: 16516335
[TBL] [Abstract][Full Text] [Related]
5. Defending the mucosa: adjuvant and carrier formulations for mucosal immunity.
Lawson LB; Norton EB; Clements JD
Curr Opin Immunol; 2011 Jun; 23(3):414-20. PubMed ID: 21511452
[TBL] [Abstract][Full Text] [Related]
6. Synthetic polyacrylate polymers as particulate intranasal vaccine delivery systems for the induction of mucosal immune response.
Zaman M; Simerska P; Toth I
Curr Drug Deliv; 2010 Apr; 7(2):118-24. PubMed ID: 20158484
[TBL] [Abstract][Full Text] [Related]
7. Mucosal adjuvants and delivery systems for protein-, DNA- and RNA-based vaccines.
Vajdy M; Srivastava I; Polo J; Donnelly J; O'Hagan D; Singh M
Immunol Cell Biol; 2004 Dec; 82(6):617-27. PubMed ID: 15550120
[TBL] [Abstract][Full Text] [Related]
8. Mucosal immunity: overcoming the barrier for induction of proximal responses.
McKenzie BS; Brady JL; Lew AM
Immunol Res; 2004; 30(1):35-71. PubMed ID: 15258310
[TBL] [Abstract][Full Text] [Related]
9. Adjuvants and delivery systems based on polymeric nanoparticles for mucosal vaccines.
Jin Z; Gao S; Cui X; Sun D; Zhao K
Int J Pharm; 2019 Dec; 572():118731. PubMed ID: 31669213
[TBL] [Abstract][Full Text] [Related]
10. Lipid-Based Particles: Versatile Delivery Systems for Mucosal Vaccination against Infection.
Corthésy B; Bioley G
Front Immunol; 2018; 9():431. PubMed ID: 29563912
[TBL] [Abstract][Full Text] [Related]
11. Delivery strategies to enhance oral vaccination against enteric infections.
Davitt CJ; Lavelle EC
Adv Drug Deliv Rev; 2015 Aug; 91():52-69. PubMed ID: 25817337
[TBL] [Abstract][Full Text] [Related]
12. Devices and formulations for pulmonary vaccination.
Tonnis WF; Lexmond AJ; Frijlink HW; de Boer AH; Hinrichs WL
Expert Opin Drug Deliv; 2013 Oct; 10(10):1383-97. PubMed ID: 23786408
[TBL] [Abstract][Full Text] [Related]
13. Rational application of nanoadjuvant for mucosal vaccine delivery system.
Dewangan HK
J Immunol Methods; 2020; 481-482():112791. PubMed ID: 32387695
[TBL] [Abstract][Full Text] [Related]
14. Nasal vaccine innovation.
Jabbal-Gill I
J Drug Target; 2010 Dec; 18(10):771-86. PubMed ID: 21047271
[TBL] [Abstract][Full Text] [Related]
15. Archaeal lipid mucosal vaccine adjuvant and delivery system.
Patel GB; Chen W
Expert Rev Vaccines; 2010 Apr; 9(4):431-40. PubMed ID: 20370552
[TBL] [Abstract][Full Text] [Related]
16. Dendritic cell-targeting DNA-based nasal adjuvants for protective mucosal immunity to Streptococcus pneumoniae.
Kataoka K; Fukuyama Y; Briles DE; Miyake T; Fujihashi K
Microbiol Immunol; 2017 Jun; 61(6):195-205. PubMed ID: 28463465
[TBL] [Abstract][Full Text] [Related]
17. Immunity in response to particulate antigen-delivery systems.
Storni T; Kündig TM; Senti G; Johansen P
Adv Drug Deliv Rev; 2005 Jan; 57(3):333-55. PubMed ID: 15560945
[TBL] [Abstract][Full Text] [Related]
18. Mucosal immunization: a review of strategies and challenges.
Patel H; Yewale C; Rathi MN; Misra A
Crit Rev Ther Drug Carrier Syst; 2014; 31(4):273-303. PubMed ID: 25072196
[TBL] [Abstract][Full Text] [Related]
19. Attachment of class B CpG ODN onto DOTAP/DC-chol liposome in nasal vaccine formulations augments antigen-specific immune responses in mice.
Tada R; Muto S; Iwata T; Hidaka A; Kiyono H; Kunisawa J; Aramaki Y
BMC Res Notes; 2017 Jan; 10(1):68. PubMed ID: 28126014
[TBL] [Abstract][Full Text] [Related]
20. Mucosal vaccines: a paradigm shift in the development of mucosal adjuvants and delivery vehicles.
Srivastava A; Gowda DV; Madhunapantula SV; Shinde CG; Iyer M
APMIS; 2015 Apr; 123(4):275-88. PubMed ID: 25630573
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
